Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
CD25(+)CD4(+) regulatory T cells in normal animals are engaged in the maintenance of immunological self-tolerance. We show here that glucocorticoid-induced tumor necrosis factor receptor family-related gene (GITR, also known as TNFRSF18)--a member of the tumor necrosis factor-nerve growth factor (TNF-NGF) receptor gene superfamily--is predominantly expressed on CD25(+)CD4(+) T cells and on CD25(+)CD4(+)CD8(-) thymocytes in normal naïve mice. We found that stimulation of GITR abrogated CD25(+)CD4(+) T cell-mediated suppression. In addition, removal of GITR-expressing T cells or administration of a monoclonal antibody to GITR produced organ-specific autoimmune disease in otherwise normal mice. Thus, GITR plays a key role in dominant immunological self-tolerance maintained by CD25(+)CD4(+) regulatory T cells and could be a suitable molecular target for preventing or treating autoimmune disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GITR can reduce T cell apoptosis and increase T cell activity through its interaction with its ligand (GITRL) (McHugh et al., 2002; Shimizu et al., 2002).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Shimizu et al., 2002
Citations
Cites
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Self-citationNagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
Suda, T., Takahashi, T., Golstein, P., & Nagata, S. (1993) · Cell · doi:10.1016/0092-8674(93)90326-l · Cited by 2,489
Self-citationTakahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., & Sakaguchi, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.303 · Cited by 2,233
Self-citationRead, S., Malmström, V., & Powrie, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.295 · Cited by 2,205
Salomon, B., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., & Bluestone, J. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80195-8 · Cited by 2,081
Sakaguchi, S. (2000) · Cell · doi:10.1016/s0092-8674(00)80856-9 · Cited by 1,815
Self-citation
Cited by
Items 101–196 of 196
Cobbold, S. P., Castejon, R., Adams, E., Zelenika, D., Graca, L., Humm, S., & Waldmann, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6003 · Cited by 410
Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy
Colombo, M. P., & Piconese, S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2250 · Cited by 407
OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection
Piconese, S., Valzasina, B., & Colombo, M. P. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071341 · Cited by 405
Zeiser, R., Leveson-Gower, D. B., Zambricki, E. A., Kambham, N., Beilhack, A., Loh, J., Hou, J.-Z., & Negrin, R. S. (2008) · Blood · doi:10.1182/blood-2007-06-094482 · Cited by 402
Lages, C. S., Suffia, I., Velilla, P. A., Huang, B., Warshaw, G., Hildeman, D. A., Belkaid, Y., & Chougnet, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1835 · Cited by 399
“Tregs from elderly and young subjects express the same functional markers We then assessed the expression of markers on FOXP3 CD4 T cells that have been previously associated with Treg phenotype and function (52), such as CD25, CTLA-4, and GITR.”
BackgroundInfluentialde Kleer, I. M., Wedderburn, L. R., Taams, L. S., Patel, A., Varsani, H., Klein, M., de Jager, W., Pugayung, G., Giannoni, F., Rijkers, G., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6435 · Cited by 400
(2010) · Advances in Cancer Research · doi:10.1016/s0065-230x(10)07003-x · Cited by 386
Cosmi, L., Liotta, F., Lazzeri, E., Francalanci, M., Angeli, R., Mazzinghi, B., Santarlasci, V., Manetti, R., Vanini, V., Romagnani, P., et al. (2003) · Blood · doi:10.1182/blood-2003-04-1320 · Cited by 383
Distinct roles of CTLA‐4 and TGF‐β in CD4+CD25+ regulatory T cell function
Tang, Q., Boden, E. K., Henriksen, K. J., Bour‐Jordan, H., Bi, M., & Bluestone, J. A. (2004) · European Journal of Immunology · doi:10.1002/eji.200425143 · Cited by 377
Lee, I., Wang, L., Wells, A. D., Dorf, M. E., Ozkaynak, E., & Hancock, W. W. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041709 · Cited by 371
CD25− T Cells Generate CD25+Foxp3+ Regulatory T Cells by Peripheral Expansion
Curotto de Lafaille, M. A., Lino, A. C., Kutchukhidze, N., & Lafaille, J. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7259 · Cited by 368
Cao, D., Vollenhoven, R. V., Klareskog, L., Trollmo, C., & Malmström, V. (2004) · Arthritis Res Ther · doi:10.1186/ar1192 · Cited by 359
Ronchetti, S., Zollo, O., Bruscoli, S., Agostini, M., Bianchini, R., Nocentini, G., Ayroldi, E., & Riccardi, C. (2004) · European Journal of Immunology · doi:10.1002/eji.200324804 · Cited by 359
CD4+CD25+ Regulatory T Cells Control the Severity of Viral Immunoinflammatory Lesions
Suvas, S., Azkur, A. K., Kim, B. S., Kumaraguru, U., & Rouse, B. T. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4123 · Cited by 358
Control of Immune Responses by Antigen-Specific Regulatory T Cells Expressing the Folate Receptor
Yamaguchi, T., Hirota, K., Nagahama, K., Ohkawa, K., Takahashi, T., Nomura, T., & Sakaguchi, S. (2007) · Immunity · doi:10.1016/j.immuni.2007.04.017 · Cited by 357
Self-citationThe promise and challenges of immune agonist antibody development in cancer
Mayes, P. A., Hance, K. W., & Hoos, A. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.75 · Cited by 355
Kriegel, M. A., Lohmann, T., Gabler, C., Blank, N., Kalden, J. R., & Lorenz, H.-M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032158 · Cited by 351
McGuirk, P., & Mills, K. H. G. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02288-3 · Cited by 350
Cesana, G. C., DeRaffele, G., Cohen, S., Moroziewicz, D., Mitcham, J., Stoutenburg, J., Cheung, K., Hesdorffer, C., Kim-Schulze, S., & Kaufman, H. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6830 · Cited by 349
Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β
Palomares, O., Martín-Fontecha, M., Lauener, R., Traidl-Hoffmann, C., Cavkaytar, O., Akdis, M., & Akdis, C. A. (2014) · Genes & Immunity · doi:10.1038/gene.2014.45 · Cited by 347
Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells
Tone, M., Tone, Y., Adams, E., Yates, S. F., Frewin, M. R., Cobbold, S. P., & Waldmann, H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2334901100 · Cited by 345
Phenotypic characterization of regulatory T cells in the human decidua
HEIKKINEN, J., MÖTTÖNEN, M., ALANEN, A., & LASSILA, O. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02441.x · Cited by 343
Human FoxP3+ regulatory T cells in systemic autoimmune diseases
Miyara, M., Gorochov, G., Ehrenstein, M., Musset, L., Sakaguchi, S., & Amoura, Z. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.004 · Cited by 342
Self-citationEngagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease
Paust, S., Lu, L., McCarty, N., & Cantor, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403342101 · Cited by 328
Möttönen, M., Heikkinen, J., Mustonen, L., Isomäki, P., Luukkainen, R., & Lassila, O. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02754.x · Cited by 320
High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells
Manavalan, J. S., Rossi, P. C., Vlad, G., Piazza, F., Yarilina, A., Cortesini, R., Mancini, D., & Suciu-Foca, N. (2003) · Transplant Immunology · doi:10.1016/s0966-3274(03)00058-3 · Cited by 319
T regulatory cells in atopic dermatitis and subversion of their activity by superantigens
Ou, L.-S., Goleva, E., Hall, C., & Leung, D. Y. M. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.01.772 · Cited by 319
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy
Grohmann, U., Volpi, C., Fallarino, F., Bozza, S., Bianchi, R., Vacca, C., Orabona, C., Belladonna, M. L., Ayroldi, E., Nocentini, G., et al. (2007) · Nature Medicine · doi:10.1038/nm1563 · Cited by 318
Franceschini, D., Paroli, M., Francavilla, V., Videtta, M., Morrone, S., Labbadia, G., Cerino, A., Mondelli, M. U., & Barnaba, V. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36604 · Cited by 318
Functional Impairment of CD8+ T Cells by Regulatory T Cells during Persistent Retroviral Infection
Dittmer, U., He, H., Messer, R. J., Schimmer, S., Olbrich, A. R. M., Ohlen, C., Greenberg, P. D., Stromnes, I. M., Iwashiro, M., Sakaguchi, S., et al. (2004) · Immunity · doi:10.1016/s1074-7613(04)00054-8 · Cited by 316
Self-citationGolshayan, D., Jiang, S., Tsang, J., Garin, M. I., Mottet, C., & Lechler, R. I. (2007) · Blood · doi:10.1182/blood-2006-05-025460 · Cited by 313
Robinson, D. S., Larché, M., & Durham, S. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423595 · Cited by 313
CCR6 expression defines regulatory effector/memory-like cells within the CD25+CD4+ T-cell subset
Kleinewietfeld, M., Puentes, F., Borsellino, G., Battistini, L., Rötzschke, O., & Falk, K. (2005) · Blood · doi:10.1182/blood-2004-07-2505 · Cited by 312
Antigen-induced regulatory T cells in autoimmunity
von Herrath, M. G., & Harrison, L. C. (2003) · Nature Reviews Immunology · doi:10.1038/nri1029 · Cited by 311
Distinct Roles for the OX40-OX40 Ligand Interaction in Regulatory and Nonregulatory T Cells
Takeda, I., Ine, S., Killeen, N., Ndhlovu, L. C., Murata, K., Satomi, S., Sugamura, K., & Ishii, N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3580 · Cited by 308
Koyama, S., & Nishikawa, H. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002591 · Cited by 305
CD25+ cell depletion hastens the onset of severe disease in collagen‐induced arthritis
Morgan, M. E., Sutmuller, R. P. M., Witteveen, H. J., van Duivenvoorde, L. M., Zanelli, E., Melief, C. J. M., Snijders, A., Offringa, R., de Vries, R. R. P., & Toes, R. E. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11063 · Cited by 305
Szczepanski, M. J., Szajnik, M., Czystowska, M., Mandapathil, M., Strauss, L., Welsh, A., Foon, K. A., Whiteside, T. L., & Boyiadzis, M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3010 · Cited by 303
Beyer, M., Kochanek, M., Giese, T., Endl, E., Weihrauch, M. R., Knolle, P. A., Classen, S., & Schultze, J. L. (2006) · Blood · doi:10.1182/blood-2005-09-3671 · Cited by 301
HIV Infection of Naturally Occurring and Genetically Reprogrammed Human Regulatory T-cells
Oswald-Richter, K., Grill, S. M., Shariat, N., Leelawong, M., Sundrud, M. S., Haas, D. W., & Unutmaz, D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020198 · Cited by 301
Regulatory T cells in the treatment of disease
Sharabi, A., Tsokos, M. G., Ding, Y., Malek, T. R., Klatzmann, D., & Tsokos, G. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.148 · Cited by 297
Bresson, D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27191 · Cited by 293
CD4+CD25+ Regulatory T Cells Cure Murine Colitis: The Role of IL-10, TGF-β, and CTLA4
Liu, H., Hu, B., Xu, D., & Liew, F. Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5012 · Cited by 293
Some interfaces of dendritic cell biology
STEINMAN, R. M. (2003) · APMIS · doi:10.1034/j.1600-0463.2003.11107802.x · Cited by 292
CD40 Ligation Releases Immature Dendritic Cells from the Control of Regulatory CD4+CD25+ T Cells
Serra, P., Amrani, A., Yamanouchi, J., Han, B., Thiessen, S., Utsugi, T., Verdaguer, J., & Santamaria, P. (2003) · Immunity · doi:10.1016/s1074-7613(03)00327-3 · Cited by 291
Distinct IL-2 Receptor Signaling Pattern in CD4+CD25+ Regulatory T Cells
Bensinger, S. J., Walsh, P. T., Zhang, J., Carroll, M., Parsons, R., Rathmell, J. C., Thompson, C. B., Burchill, M. A., Farrar, M. A., & Turka, L. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5287 · Cited by 289
Kanamaru, F., Youngnak, P., Hashiguchi, M., Nishioka, T., Takahashi, T., Sakaguchi, S., Ishikawa, I., & Azuma, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7306 · Cited by 285
Self-citationControl of Autoimmunity by Naturally Arising Regulatory CD4+ T Cells
(2003) · Advances in Immunology · doi:10.1016/s0065-2776(03)81008-8 · Cited by 283
Persistence of naive CD45RA+ regulatory T cells in adult life
Seddiki, N., Santner-Nanan, B., Tangye, S. G., Alexander, S. I., Solomon, M., Lee, S., Nanan, R., & de Saint Groth, B. F. (2006) · Blood · doi:10.1182/blood-2005-06-2403 · Cited by 284
Mahmud, S. A., Manlove, L. S., Schmitz, H. M., Xing, Y., Wang, Y., Owen, D. L., Schenkel, J. M., Boomer, J. S., Green, J. M., Yagita, H., et al. (2014) · Nature Immunology · doi:10.1038/ni.2849 · Cited by 281
The GITR–GITRL interaction: co-stimulation or contrasuppression of regulatory activity?
Shevach, E. M., & Stephens, G. L. (2006) · Nature Reviews Immunology · doi:10.1038/nri1867 · Cited by 281
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
Quezada, S. A., Peggs, K. S., Simpson, T. R., & Allison, J. P. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01007.x · Cited by 276
Regulatory T cells and intestinal homeostasis
Coombes, J. L., Robinson, N. J., Maloy, K. J., Uhlig, H. H., & Powrie, F. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00250.x · Cited by 275
Erhardt, A., Biburger, M., Papadopoulos, T., & Tiegs, G. (2007) · Hepatology · doi:10.1002/hep.21498 · Cited by 267
Advances in targeting cell surface signalling molecules for immune modulation
Yao, S., Zhu, Y., & Chen, L. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3877 · Cited by 267
Liang, S., Alard, P., Zhao, Y., Parnell, S., Clark, S. L., & Kosiewicz, M. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041201 · Cited by 267
Role of regulatory T cells in human diseases
Chatila, T. A. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.08.047 · Cited by 265
CD4+CD25bright T Cells in Human Intestinal Lamina Propria as Regulatory Cells
Makita, S., Kanai, T., Oshima, S., Uraushihara, K., Totsuka, T., Sawada, T., Nakamura, T., Koganei, K., Fukushima, T., & Watanabe, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3119 · Cited by 264
Immunoregulatory T cells in tumor immunity
Terabe, M., & Berzofsky, J. A. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.01.010 · Cited by 264
Regulatory T cells in immune surveillance and treatment of cancer
Yamaguchi, T., & Sakaguchi, S. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.11.005 · Cited by 263
Self-citationInhibition of Human CD4+CD25+high Regulatory T Cell Function
Baecher-Allan, C., Viglietta, V., & Hafler, D. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6210 · Cited by 262
Cohen, A. D., Schaer, D. A., Liu, C., Li, Y., Hirschhorn-Cymmerman, D., Kim, S. C., Diab, A., Rizzuto, G., Duan, F., Perales, M. A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010436 · Cited by 261
Yamazaki, S., Inaba, K., Tarbell, K. V., & Steinman, R. M. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00422.x · Cited by 259
Self-citationValzasina, B., Piconese, S., Guiducci, C., & Colombo, M. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4217 · Cited by 259
Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
Mei, Z., Huang, J., Qiao, B., & Lam, A. K.-Y. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0084-8 · Cited by 257
T Cell Regulation as a Side Effect of Homeostasis and Competition
Barthlott, T., Kassiotis, G., & Stockinger, B. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021387 · Cited by 256
Regulatory T cells in virus infections
Rouse, B. T., Sarangi, P. P., & Suvas, S. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00412.x · Cited by 255
Segundo, D. S., Ruiz, J. C., Izquierdo, M., Fernández-Fresnedo, G., Gómez-Alamillo, C., Merino, R., Benito, M. J., Cacho, E., Rodrigo, E., Palomar, R., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000229473.95202.50 · Cited by 249
“We used GITR as a marker for Tregs although its expression is increased upon T cell activation, and signaling through it has been shown to reverse suppressive activity of Tregs (26).”
MethodBreous, E., Somanathan, S., Vandenberghe, L. H., & Wilson, J. M. (2009) · Hepatology · doi:10.1002/hep.23043 · Cited by 237
Targeting regulatory T cells in tumors
Liu, C., Workman, C. J., & Vignali, D. A. A. (2016) · The FEBS Journal · doi:10.1111/febs.13656 · Cited by 228
Cao, O., Dobrzynski, E., Wang, L., Nayak, S., Mingle, B., Terhorst, C., & Herzog, R. W. (2007) · Blood · doi:10.1182/blood-2007-02-073304 · Cited by 220
Treg cells in autoimmunity: from identification to Treg-based therapies
Göschl, L., Scheinecker, C., & Bonelli, M. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00741-8 · Cited by 214
Role of intestinal flora in the development of allergy
Kalliomäki, M., & Isolauri, E. (2003) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200302000-00003 · Cited by 210
Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model
Castano, A. P., Mroz, P., Wu, M. X., & Hamblin, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709256105 · Cited by 201
“Several molecules have been implicated in the suppressor mechanism underlying the immunoregulatory function of CD4 FoxP3 T cells, including cell surface molecules such as CTLA-4 and glucocorticoid-induced tumor necrosis factor receptor (40), and secreted molecules such as TGF- 1 and IL-10 (41).”
BackgroundJi, H.-B., Liao, G., Faubion, W. A., Abadía-Molina, A. C., Cozzo, C., Laroux, F. S., Caton, A., & Terhorst, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.5823 · Cited by 198
Yamazaki, S., Bonito, A. J., Spisek, R., Dhodapkar, M., Inaba, K., & Steinman, R. M. (2007) · Blood · doi:10.1182/blood-2007-05-088831 · Cited by 194
Self-citationNocentini, G., & Riccardi, C. (2005) · European Journal of Immunology · doi:10.1002/eji.200425818 · Cited by 179
“More interestingly, adding anti-GITR Ab to cocultures of murine responder (CD4+CD25–) and suppressor (CD4+CD25+) cells completely abrogated suppression [ 11 , 15].”
BackgroundInfluentialLu, L., Xu, X., Zhang, B., Zhang, R., Ji, H., & Wang, X. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-36 · Cited by 177
“Each dot represents the data from each mouse and Data are CD4+FoxP3- T cells and CD8+ T cells and attenuated the frequencies of Treg and MDSC; however, single PD-1 had little effect on these subsets.”
BackgroundInfluentialNakagawa, H., Sido, J. M., Reyes, E. E., Kiers, V., Cantor, H., & Kim, H.-J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604765113 · Cited by 176
Basic Overview of Current Immunotherapy Approaches in Cancer
Velcheti, V., & Schalper, K. (2016) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_156572 · Cited by 176
TGF-β: the perpetrator of immune suppression by regulatory T cells and suicidal T cells
Wahl, S. M., Swisher, J., McCartney-Francis, N., & Chen, W. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1103539 · Cited by 172
“In contrast to CTLA-4-augmented Treg function, GITR represents a counterbalance, and signaling through GITR blunts or reverses suppression [59, 60], although the functional mechanism remains elusive.”
BackgroundWolf, N., Quaranta, M., Prescott, N. J., Allen, M., Smith, R., Burden, A. D., Worthington, J., Griffiths, C. E. M., Mathew, C. G., Barker, J. N., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2007.053595 · Cited by 171
“is a mediator of nuclear factor kappa-b signalling and is a key molecule for the maintenance of immunological self-tolerance,”
BackgroundKim, I.-K., Kim, B.-S., Koh, C.-H., Seok, J.-W., Park, J.-S., Shin, K.-S., Bae, E.-A., Lee, G.-E., Jeon, H., Cho, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3922 · Cited by 167
Ono, M., Shimizu, J., Miyachi, Y., & Sakaguchi, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4748 · Cited by 162
Self-citationNiedbala, W., Cai, B., Liu, H., Pitman, N., Chang, L., & Liew, F. Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703725104 · Cited by 156
Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications
Rutella, S., & Lemoli, R. M. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.04.015 · Cited by 147
Retinoic acid in the immune system
Pino‐Lagos, K., Benson, M. J., & Noelle, R. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.017 · Cited by 138
Hamdi, H., Godot, V., Maillot, M.-C., Prejean, M. V., Cohen, N., Krzysiek, R., Lemoine, F. M., Zou, W., & Emilie, D. (2007) · Blood · doi:10.1182/blood-2006-10-052506 · Cited by 126
A Potential Role for Estrogen in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
OFFNER, H., & POLANCZYK, M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1386.021 · Cited by 102
Katz, S. C., Ryan, K., Ahmed, N., Plitas, G., Chaudhry, U. I., Kingham, T. P., Naheed, S., Nguyen, C., Somasundar, P., Espat, N. J., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004077 · Cited by 79
Hoffman, B. E., Martino, A. T., Sack, B. K., Cao, O., Liao, G., Terhorst, C., & Herzog, R. W. (2011) · Molecular Therapy · doi:10.1038/mt.2011.33 · Cited by 72
Dendritic Cells and T Cells in the Regulation of Cutaneous Immunity
Loser, K., & Beissert, S. (2007) · Advances in Dermatology · doi:10.1016/j.yadr.2007.07.014 · Cited by 52
Durham, N. M., Holoweckyj, N., MacGill, R. S., McGlinchey, K., Leow, C. C., & Robbins, S. H. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0247-0 · Cited by 48
Dendritic cells combined with anti-GITR antibody produce antitumor effects in osteosarcoma
KAWANO, M., TANAKA, K., ITONAGA, I., IWASAKI, T., MIYAZAKI, M., IKEDA, S., & TSUMURA, H. (2015) · Oncology Reports · doi:10.3892/or.2015.4161 · Cited by 38
Gabriel, S. S., Bon, N., Chen, J., Wekerle, T., Bushell, A., Fehr, T., & Cippà, P. E. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00073 · Cited by 20
“5) (Bio-X-cell), and GITR [DTA-1, provided by Sakaguchi (26)] were diluted in PBS and injected i.”
MethodInfluentialCD8 T Cell–Independent Antitumor Response and Its Potential for Treatment of Malignant Gliomas
Murphy, K., & Griffith, T. (2016) · Cancers · doi:10.3390/cancers8080071 · Cited by 11
Metadata
- Authors
- Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y., & Sakaguchi, S.
- Affiliations
- Tokyo Metropolitan Institute of Gerontology (JP)
- Kyoto University (JP)
- Nara Institute of Science and Technology (JP)
- Corresponding author
- Sakaguchi, Shimon
- Venue
- Nature Immunology
- Published
- 2002-01-22
- Volume
- 3
- Issue
- 2
- Pages
- 135-142
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2026426963
- Cited by
- 1,729
- References
- 47
- Citations by year
- 2026: 14 · 2025: 20 · 2024: 35 · 2023: 40 · 2022: 47 · 2021: 34 · 2020: 49 · 2019: 56 · 2018: 41 · 2017: 48 · 2016: 49 · 2015: 54 · 2014: 55 · 2013: 61 · 2012: 76
- FWCI
- 42.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Soochow University
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- GITR, regulatory T cells, CD4+CD25+ T cells, self-tolerance, autoimmune disease, T cell-mediated suppression, thymocytes, autoimmune disease prevention
- MeSH terms
- Animals, Autoimmune Diseases, Glycoproteins, Immune Tolerance, Lymph Nodes, Mice, Inbred BALB C, Spleen, Receptors, Interleukin-2, Signal Transduction, CD4-Positive T-Lymphocytes, CD4 Antigens, T-Lymphocyte Subsets, Rats, Wistar, Receptors, Nerve Growth Factor, Receptors, Tumor Necrosis Factor, Dimerization, Mice, Rats, Glucocorticoid-Induced TNFR-Related Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.